David J. Straus, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the latest clinical trials in lymphoma, including an ongoing study evaluating interim PET scans to tailor treatment in stage III/IV disease in addition to an ongoing study evaluating brentuximab vedotin and nivolumab, also in stage III/IV disease. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).